Cardiovascular MR Perfusion Imaging: Good Initial Alternative in Stable Chronic Angina

Cardiovascular MR Perfusion ImagingIn the initial management of patients with stable chronic angina, a non-invasive strategy with cardiovascular MR perfusion imaging seems to provide similar results to invasive strategies.

 

At one year, MACE rate (combination of all cause death, non-fatal infarction and target vessel revascularization) resulted 3.3% for MRI vs. 3.9% for fractional flow reserve (FFR) informed invasive strategy. This difference was not significant (p=0.62). Outcomes were similar, despite the lower revascularization rate in the MRI arm (36.0% vs. 44.2%; p= 0.0053).

 

Cardiovascular MR perfusion imaging could be considered the best non-invasive alternative available, since it provides information on anatomy, function and myocardial structure in one single study with no use of iodine radiation.

 

The study randomized 918 patients with chronic stable angina (functional class II or III) at intermediate to high risk of coronary artery disease justified by at least two cardiovascular risk factors and one positive exercise treadmill test. All patients received OMT for risk factor control.

 

The invasive group received angiography and FFR in all >2.5 mm arteries with 40% – 95% stenosis.  Revascularization was performed when FFR value was ˂0.8.

 

We could conclude that non-invasive initial management of stable chronic angina with cardiovascular MRI was non-inferior to angiography with FFR at one year follow up.

 

Original Title: MR-INFORM: stress perfusion imaging to guide the management of patients with stable coronary artery disease.

Presenter: Nagel EC.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TRILUMINATE: Liver and Kidney Failure in Tricuspid Valve Edge-to-Edge Repair

Severe tricuspid regurgitation (TR) will affect roughly 3% of the 65+ population and may lead to liver and kidney failure, which will cause ascites...

Secondary Access in TAVI: Is Transradial Approach our Best Bet?

In some countries, transcatheter aortic valve implantation (TAVI) has become the treatment of choice for patients with severe symptomatic aortic stenosis. Primary transfemoral access...

Asymptomatic Aortic Stenosis: A Complex Decision

Asymptomatic severe aortic stenosis continues to pose a significant challenge when it comes to clinical decision-making, often due to the difficulty in identifying symptoms....

TAVI and Aortic Regurgitation: Are All Valves the Same?

Aortic regurgitation (AR) accounts for 0.5- 2.2% of all cases of valve disease in individuals over 65 years old. According to current guidelines, surgery is...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TRILUMINATE: Liver and Kidney Failure in Tricuspid Valve Edge-to-Edge Repair

Severe tricuspid regurgitation (TR) will affect roughly 3% of the 65+ population and may lead to liver and kidney failure, which will cause ascites...

Secondary Access in TAVI: Is Transradial Approach our Best Bet?

In some countries, transcatheter aortic valve implantation (TAVI) has become the treatment of choice for patients with severe symptomatic aortic stenosis. Primary transfemoral access...

FAVOR III Europa Sub-Analysis: Coronary Revascularization Deferral Based On QFR vs FFR

When it comes to intermediate coronary lesion revascularization decision making, functional assessment is the recommended. At present, several indices are used, such as fractional...